Medacta Group S.A.
MEDGF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2 | $2 | $2 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $2 | $2 | $3 |
| Revenue | $1 | $1 | $0 | $0 |
| % Growth | 15.6% | 16.9% | 20.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 67.6% | 68.1% | 69.8% | 71.9% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 27.2% | 23.4% | 24.5% | 26.9% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 12.3% | 9.3% | 10.6% | 14.2% |
| EPS Diluted | 3.65 | 2.37 | 2.31 | 2.58 |
| % Growth | 54% | 2.6% | -10.5% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | $0 | $0 |